High Body Mass Index is Associated with Increased Risk of Treatment Failure and Surgery in Biologic-treated Patients with Ulcerative Colitis

BACKGROUND: Though pharmacokinetic studies suggest accelerated biologic drug clearance with increasing body weight, evidence of obesity’s impact on clinical outcomes in biologic-treated patients with ulcerative colitis (UC) is inconsistent. AIMS: We evaluated the impact of obesity on real world resp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Aliment Pharmacol Ther
Autors principals: Kurnool, Soumya, Nguyen, Nghia H., Proudfoot, James, Dulai, Parambir S., Boland, Brigid S., Casteele, Niels Vande, Evans, Elisabeth, Grunvald, Eduardo L., Zarrinpar, Amir, Sandborn, William J., Singh, Siddharth
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992082/
https://ncbi.nlm.nih.gov/pubmed/29665045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14665
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars